GlassScriptPhysician profile
Hemant Chaparala
NPI 1043666365
$32,810.86
in general payments reported to CMS, 2019-2025
30 companies · $1,711 in 2025
The $1,711 reported for 2025 was more than what 76% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $25K · 2022: $2,474 · 2023: $1,994 · 2024: $1,596 · 2025: $1,711.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,706 · Travel and Lodging: $495 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,706.35 |
| Travel and Lodging | $495.05 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $25,341.14 | 2021-2024 | Lithovue, Spaceoar Vue System - 10ml, Lumenis Pulse 100h |
| Teleflex LLC | $2,664.68 | 2022-2025 | Urolift, Barrigel |
| Medtronic, INC. | $2,373.54 | 2022-2025 | Interstim |
| Sumitomo Pharma America, INC. | $615.27 | 2023-2025 | Gemtesa, Orgovyx |
| Procept Biorobotics Corporation | $301.02 | 2023-2024 | Aquabeam System, Aquabeam Robotic System |
| Astellas Pharma US INC | $248.22 | 2022-2025 | Xtandi, Myrbetriq, Veozah |
| Verity Pharmaceuticals INC. | $157.92 | 2024-2025 | Tlando, Trelstar |
| Coloplast Corp | $119.39 | 2023-2025 | Speedicath |
| Tempus Ai, INC | $113.99 | 2024-2025 | Xt Cdx |
| Endo Pharmaceuticals INC. | $88.55 | 2023 | Xiaflex |
| Bayer Healthcare Pharmaceuticals INC. | $67.90 | 2022-2025 | |
| Janssen Biotech, INC. | $66.29 | 2025 | Erleada |
| Novartis Pharmaceuticals Corporation | $58.58 | 2022-2025 | |
| Urogen Pharma, INC. | $51.14 | 2025 | |
| C. R. Bard, INC. & Subsidiaries | $49.67 | 2025 | Magic3 Go Intermittent Urinary Catheter |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $47.41 | 2022 | |
| Tolmar, INC. | $44.83 | 2024 | |
| Accord Healthcare, INC. | $42.98 | 2023 | |
| Ferring Pharmaceuticals INC. | $42.02 | 2024-2025 | Adstiladrin |
| Astrazeneca Pharmaceuticals LP | $40.43 | 2023 | Lynparza |
| Urovant Sciences INC | $40.04 | 2022 | |
| Abc Home Medical Supply, INC. | $39.66 | 2023-2025 | |
| Antares Pharma, INC. | $33.39 | 2022-2024 | Xyosted |
| Olympus America INC. | $30.76 | 2024-2025 | Itind System |
| Vertex Pharmaceuticals Incorporated | $29.65 | 2024 | |
| Convatec INC. | $24.32 | 2022 | |
| Merck Sharp & Dohme LLC | $22.97 | 2022 | |
| Endo USA, INC. | $21.12 | 2024 | Xiaflex |
| Laborie Medical Technologies Corp. | $19.46 | 2023 | |
| Abbvie INC. | $14.52 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hemant Chaparala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.